Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06550375 · ClinicalTrials.gov registry record
Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
A clinical trial of Cataract, sponsored by Mann Eye Institute.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06550375: Completed study of Cataract, sponsored by Mann Eye Institute.
NCT06550375 is a study of Cataract that has completed, run by Mann Eye Institute. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06550375, a study of Cataract, has completed, sponsored by Mann Eye Institute.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.
Primary Outcome
Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Conditions Studied
Interventions
- DEVICE TECNIS Odyssey IOL
Study Locations (1)
Texas
- Mann Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2025-03-26 |
What the finished NCT06550375 record still lists
NCT06550375 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which TECNIS Odyssey IOL is the first listed.
NCT06550375 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06550375 about?
NCT06550375 is a clinical study titled "Clinical Outcomes With Bilateral Implantation of Odyssey IOLs". This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurem...
What is the current status of trial NCT06550375?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2024-09-05. Estimated completion is 2025-03-26.
What conditions does trial NCT06550375 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06550375?
The interventions under investigation include: TECNIS Odyssey IOL (DEVICE).
Who is sponsoring clinical trial NCT06550375?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06550375 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06550375's enrollment target sits among peer trials
40 65th of 83 higher than 14 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI